Clinical trial
A Double Blind, Placebo-Controlled, Randomized, Phase Ib Clinical Study of ApTOLL for the Treatment of COVID-19
NCT05293236 is registered in ClinicalTrials.gov with Macarena Hernández Jiménez as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double Blind, Placebo-Controlled, Randomized, Phase Ib Clinical Study of ApTOLL for the Treatment of COVID-19
- Lead sponsor
- Macarena Hernández Jiménez
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- January 14, 2022
- Completion date
- December 31, 2022
- Enrollment
- 5 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.